More on ABT
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $107.27 |
|
|||
| Open | $106.97 | ||||
| 52 Wk High | $46.38 | ||||
| 52 Wk Low | $36.00 | ||||
| Day High | $110.04 | ||||
| Day Low | $106.97 | ||||
| P/E | 72.00 | ||||
| EPS | $1.50 | ||||
| Volume | 12,159,016 | ||||
- Form 10-Q ABBOTT LABORATORIES For: Jun 30
- Abbott Labs (ABT) PT Lowered to $125 at UBS
- FDA approves Freenome's blood-based colorectal cancer screening test
- FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
- Abbott Labs (ABT) Reiterated at Buy by Benchmark After Q2 Model Updates
- Abbott Labs (ABT) PT Raised to $117 at Bernstein SocGen Group
- Abbott Labs (ABT) Reiterated at Buy by Benchmark After Q2 Revenue Beat
- Abbott Labs (ABT) PT Raised to $120 at JPMorgan
- Abbott Labs (ABT) PT Raised to $118 at Piper Sandler
- Abbott Labs (ABT) PT Raised to $112 at Wells Fargo
Entities mentioned with ABT
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Dividend | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Show More...
